Shanghai Haoyuan Chemexpress Co., Ltd.

Shanghai Stock Exchange 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd. EPS (Diluted) for the year ending December 31, 2023: USD 0.09

Shanghai Haoyuan Chemexpress Co., Ltd. EPS (Diluted) is USD 0.09 for the year ending December 31, 2023, a -36.07% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Shanghai Haoyuan Chemexpress Co., Ltd. EPS (Diluted) for the year ending December 31, 2022 was USD 0.13, a -8.78% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. EPS (Diluted) for the year ending December 31, 2021 was USD 0.15, a 52.75% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. EPS (Diluted) for the year ending December 31, 2020 was USD 0.10, a 86.58% change year over year.
Shanghai Haoyuan Chemexpress Co., Ltd. EPS (Diluted) for the year ending December 31, 2019 was USD 0.05, a 293.74% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

Shanghai Stock Exchange: 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd.

CEO	Mr. Baofu Zheng
IPO Date	June 8, 2021
Location	China
Headquarters	No. 3 Building, No. 1999
Employees	3,370
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Key trends

Past 5 years